Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_assertion type Assertion NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_head.
- NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_assertion description "[In conclusion, PTC frequently expresses MHC Class II antigen, and the expression of MHC Class II antigen correlated inversely with the risk of recurrence of PTC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_provenance.
- NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_assertion evidence source_evidence_literature NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_provenance.
- NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_assertion SIO_000772 17957790 NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_provenance.
- NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_assertion wasDerivedFrom befree-20140225 NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_provenance.
- NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_assertion wasGeneratedBy ECO_0000203 NP937516.RApcLk-6_gzGYmbF9Hav6qEDn7g0PFS5iaYhFnTmx1mZI130_provenance.